Chang H, Tsai C, Hsu C, Tai T, Cheng M, Chuang Y
Nat Metab. 2025; .
PMID: 40045118
DOI: 10.1038/s42255-025-01245-6.
Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J
Signal Transduct Target Ther. 2024; 9(1):336.
PMID: 39617822
PMC: 11609310.
DOI: 10.1038/s41392-024-02021-w.
Hsu C, Chang Y, Li H
Biomed J. 2024; 48(1):100748.
PMID: 38796105
PMC: 11772973.
DOI: 10.1016/j.bj.2024.100748.
Li G, Yang S, Wang S, Jiang R, Xu X
Diagnostics (Basel). 2023; 13(15).
PMID: 37568893
PMC: 10417831.
DOI: 10.3390/diagnostics13152530.
Alami I, Gihbid A, Charoute H, Khaali W, Brahim S, Tawfiq N
Pan Afr Med J. 2022; 41:6.
PMID: 35145598
PMC: 8797042.
DOI: 10.11604/pamj.2022.41.6.28946.
Association of Systemic Inflammation and Malnutrition With Survival in Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: Results From a Multicenter Cohort Study.
Wang X, Yang M, Ge Y, Tang M, Rao B, Chen Y
Front Oncol. 2021; 11:766398.
PMID: 34765561
PMC: 8576523.
DOI: 10.3389/fonc.2021.766398.
Design of InnoPrimers-Duplex Real-Time PCR for Detection and Treatment Response Prediction of EBV-Associated Nasopharyngeal Carcinoma Circulating Genetic Biomarker.
Abusalah M, Binti Hassan S, Mat Lazim N, Abdullah B, Wan Sohaimi W, Husin A
Diagnostics (Basel). 2021; 11(10).
PMID: 34679459
PMC: 8534743.
DOI: 10.3390/diagnostics11101761.
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment.
Li H, Huang C, Lui K, Chao Y, Yeh C, Lee L
Cancers (Basel). 2021; 13(12).
PMID: 34204797
PMC: 8231497.
DOI: 10.3390/cancers13122954.
Effects of Epstein-Barr Virus Infection on the Risk and Prognosis of Primary Laryngeal Squamous Cell Carcinoma: A Hospital-Based Case-Control Study in Taiwan.
Lee L, Fang T, Li H, Chuang H, Kang C, Chang K
Cancers (Basel). 2021; 13(7).
PMID: 33917480
PMC: 8038767.
DOI: 10.3390/cancers13071741.
Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy.
Li W, Hua X, Xie D, Liang H, Liu G, Xia W
ESMO Open. 2021; 6(1):100004.
PMID: 33399071
PMC: 7807936.
DOI: 10.1016/j.esmoop.2020.100004.
[Effect of exosomes derived from human Epstein-Barr virus-positive nasopharyngeal carcinoma cells on lymphangiogenesis and lymph node metastasis].
Chen X, Li D, Huang Z, Zhong S, Cai L
Nan Fang Yi Ke Da Xue Xue Bao. 2020; 40(12):1776-1783.
PMID: 33380393
PMC: 7835692.
DOI: 10.12122/j.issn.1673-4254.2020.12.12.
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan S, Chan S, Choi H, Tong C, Lam K, Kwong D
Front Oncol. 2020; 10:1417.
PMID: 32974150
PMC: 7472777.
DOI: 10.3389/fonc.2020.01417.
Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study.
Li W, Lv S, Liu G, Liang H, Guo X, Lv X
Int J Radiat Oncol Biol Phys. 2020; 109(1):120-130.
PMID: 32853711
PMC: 9107935.
DOI: 10.1016/j.ijrobp.2020.08.045.
Establishing M1 stage subdivisions by incorporating radiological features and Epstein-Barr virus DNA for metastatic nasopharyngeal carcinoma.
Zheng W, He X, Chen F, Lin L, Huang X, Zhou H
Ann Transl Med. 2020; 8(4):83.
PMID: 32175376
PMC: 7048999.
DOI: 10.21037/atm.2020.01.13.
Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma-like carcinoma.
Lin C, Chang Y, Wang I, Hsieh M, Wang C, Lin S
Oncol Lett. 2019; 18(6):6143-6149.
PMID: 31788088
PMC: 6864931.
DOI: 10.3892/ol.2019.10954.
Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway.
Chung A, OuYang C, Liu H, Chao M, Luo J, Lee C
Cancer Med. 2019; 8(11):5116-5127.
PMID: 31328403
PMC: 6718742.
DOI: 10.1002/cam4.2429.
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
Hsu C, Lui K, Chi L, Kuo Y, Chao Y, Yeh C
J Exp Clin Cancer Res. 2018; 37(1):233.
PMID: 30236142
PMC: 6149192.
DOI: 10.1186/s13046-018-0873-5.
The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
Yan D, Zhang W, Ke S, Zhao F, Yan S, Wang Q
BMC Cancer. 2017; 17(1):678.
PMID: 29020937
PMC: 5637091.
DOI: 10.1186/s12885-017-3658-x.
Progesterone analogues reduce plasma Epstein-Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care.
Hung C, Lin T, Kuo Y, Hsieh C, Wang H, Hsu C
Biomed J. 2017; 40(4):212-218.
PMID: 28918909
PMC: 6136283.
DOI: 10.1016/j.bj.2017.06.006.
The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
Sun P, Chen C, Xia Y, Bi X, Liu P, Zhang F
Dis Markers. 2017; 2017:6570808.
PMID: 28676731
PMC: 5476879.
DOI: 10.1155/2017/6570808.
